381 related articles for article (PubMed ID: 16260148)
1. Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
Protein Expr Purif; 2006 May; 47(1):36-44. PubMed ID: 16260148
[TBL] [Abstract][Full Text] [Related]
2. High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
J Biotechnol; 2006 May; 123(3):367-78. PubMed ID: 16406157
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].
Zheng WY; Ma XY; Wei DZ; Wang JZ; Liu QH; Ma YS; Yang SL
Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):285-92. PubMed ID: 16607958
[TBL] [Abstract][Full Text] [Related]
4. Preparative scale culture of Escherichia coli cells expressing the human immunodeficiency virus type 1 Tat protein.
McKenna MC; Muchardt C; Gaynor R; Eisenberg D
Protein Expr Purif; 1994 Apr; 5(2):105-11. PubMed ID: 8054841
[TBL] [Abstract][Full Text] [Related]
5. Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cells.
Shen C; Liu W; Buck AK; Reske SN
Anticancer Res; 2009 Apr; 29(4):1423-8. PubMed ID: 19414397
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
7. [The fusion construction of HIV-1 Tat gene and efficient expression in E.coli].
Lin JP; Wang H; Wang L; Wei HF; Hu XP; Wang LY; Yu YL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):33-6. PubMed ID: 15629079
[TBL] [Abstract][Full Text] [Related]
8. A novel method for promoting heterologous protein expression in Escherichia coli by fusion with the HIV-1 TAT core domain.
Wu Y; Ren C; Gao Y; Hou B; Chen T; Zhang C
Amino Acids; 2010 Aug; 39(3):811-20. PubMed ID: 20213440
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of recombinant HIV-1 tat protein using HIV-1-tat specific monoclonal antibodies.
Demirhan I; Hofmann D; Chandra A; Hasselmayer O; Chandra P
Anticancer Res; 2000; 20(4):2377-81. PubMed ID: 10953299
[TBL] [Abstract][Full Text] [Related]
10. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
[TBL] [Abstract][Full Text] [Related]
11. [Expression, purification and transduction of Tat-p53 fusion protein].
Ding J; Liu J; Huang YX; Li YH; Chen J; Zhao Y; Xue CF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):587-90. PubMed ID: 16143063
[TBL] [Abstract][Full Text] [Related]
12. [Expression of human osteoprotegerin gene in E. Coli and bioactivity analysis of expression product].
Liu JZ; Hu YY; Ji ZL; Chen SM
Zhonghua Wai Ke Za Zhi; 2003 Sep; 41(9):641-5. PubMed ID: 14680558
[TBL] [Abstract][Full Text] [Related]
13. [Construction and expression of prokaryotic expression vector for pTAT-HBV targeted ribonuclease fusion protein].
Ding J; Liu J; Xue CF; Li YH; Gong WD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):49-51. PubMed ID: 15132905
[TBL] [Abstract][Full Text] [Related]
14. [Construction of prokaryotic expression plasmid pET15b-PEP-1-CAT and expression and purification of PEP-1-CAT fusion protein].
Yao LL; Wang JN; Huang YZ; Guo LY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1319-25. PubMed ID: 16982446
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
17. [Cloning, expression and purification of human TNF-related apoptosis-inducing ligand in Escherichia coli].
Yao GH; Luan JF; Ye D; Lei QH; Zhu PY; Jin J; Hou YY
Wei Sheng Yan Jiu; 2006 Nov; 35(6):697-700. PubMed ID: 17290744
[TBL] [Abstract][Full Text] [Related]
18. Cloning, high-yield expression in Escherichia coli, and purification of biologically active HIV-1 Tat protein.
Kirsch T; Boehm M; Schuckert O; Metzger AU; Willbold D; Frank RW; Rösch P
Protein Expr Purif; 1996 Aug; 8(1):75-84. PubMed ID: 8812837
[TBL] [Abstract][Full Text] [Related]
19. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
[TBL] [Abstract][Full Text] [Related]
20. [Reconstruction of an intracellular transduction system based on HIV-1 TAT protein transduction domain].
Guo AH; Liu ZF; Sun XG; Li HY; Deng P; Jiang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):545-8. PubMed ID: 16762844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
